Relief Therapeutics Holding SA

SWX:RLF Stock Report

Market Cap: CHF 64.0m

Relief Therapeutics Holding Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Relief Therapeutics Holding.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

We Think Relief Therapeutics Holding (VTX:RLF) Can Easily Afford To Drive Business Growth

Oct 09
We Think Relief Therapeutics Holding (VTX:RLF) Can Easily Afford To Drive Business Growth

Relief Therapeutics Holding SA's (VTX:RLF) Share Price Boosted 52% But Its Business Prospects Need A Lift Too

Sep 03
Relief Therapeutics Holding SA's (VTX:RLF) Share Price Boosted 52% But Its Business Prospects Need A Lift Too

Relief Therapeutics Holding SA (VTX:RLF) Surges 52% Yet Its Low P/S Is No Reason For Excitement

Sep 03
Relief Therapeutics Holding SA (VTX:RLF) Surges 52% Yet Its Low P/S Is No Reason For Excitement

Health Check: How Prudently Does Relief Therapeutics Holding (VTX:RLF) Use Debt?

May 05
Health Check: How Prudently Does Relief Therapeutics Holding (VTX:RLF) Use Debt?

Does Relief Therapeutics Holding (VTX:RLF) Have A Healthy Balance Sheet?

Oct 04
Does Relief Therapeutics Holding (VTX:RLF) Have A Healthy Balance Sheet?

Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?

Apr 23
Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?

Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?

Sep 25
Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?

We Wouldn't Rely On Relief Therapeutics Holding's (VTX:RLF) Statutory Earnings As A Guide

Jan 13
We Wouldn't Rely On Relief Therapeutics Holding's (VTX:RLF) Statutory Earnings As A Guide

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Relief Therapeutics Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SWX:RLF - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20249-46-2-10N/A
3/31/20247-72-5-14N/A
12/31/20236-98-9-18N/A
9/30/20236-89-15-19N/A
6/30/20236-81-20-20N/A
3/31/20236-66-23-22N/A
12/31/20226-51-25-24N/A
9/30/20226-49-29-28N/A
6/30/20227-47-33-33N/A
3/31/20225-41-41-34N/A
12/31/20213-35-49-36N/A
9/30/20212-33-48-34N/A
6/30/2021N/A-31-46-33N/A
3/31/2021N/A-19-32-26N/A
12/31/2020N/A-8-18-18N/A
9/30/2020N/A-3-11-11N/A
6/30/2020N/A1-3-3N/A
3/31/2020N/A-3-2-2N/A
12/31/2019N/A-7-1-1N/A
9/30/20190-4-1-1N/A
6/30/20191-1-1-1N/A
3/31/20191-1-1-1N/A
12/31/201810-1-1N/A
9/30/20180-1-1-1N/A
6/30/2018N/A-2-1-1N/A
3/31/2018N/A-3N/A-1N/A
12/31/2017N/A-3N/A-1N/A
9/30/20170-10N/A-2N/A
6/30/20170-18N/A-3N/A
3/31/20170-17N/A-3N/A
12/31/20160-17N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if RLF's forecast earnings growth is above the savings rate (0.3%).

Earnings vs Market: Insufficient data to determine if RLF's earnings are forecast to grow faster than the Swiss market

High Growth Earnings: Insufficient data to determine if RLF's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if RLF's revenue is forecast to grow faster than the Swiss market.

High Growth Revenue: Insufficient data to determine if RLF's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RLF's Return on Equity is forecast to be high in 3 years time


Discover growth companies